中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Exploratory Indications
Pipeline
Pipeline
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
Investors
Financials & Filing
2025
2024
2023
2022
2021
2020
2019
2018
2025
2024
2023
2022
2021
2020
2019
2018
Next Day Disclosure Returns - Others
2020-11-23
Next Day Disclosure Returns - Share Buyback
2020-11-19
Voluntary Announcement - ASC40 (TVB-2640) Phase II NASH Trial Completed Patient Enrollment in China
2020-11-19
Announcement - Change in Use of Proceeds from the Global Offering
2020-11-18
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2020
2020-11-03
Next Day Disclosure Returns - Share Buyback
2020-10-27
Next Day Disclosure Returns - Share Buyback
2020-10-21
Next Day Disclosure Returns - Share Buyback
2020-10-19
Next Day Disclosure Returns - Share Buyback
2020-10-16
Next Day Disclosure Returns - Share Buyback
2020-10-15
«
1
2
3
4
»
浙公网安备 33010802003344号
浙ICP备11050387号-1